论文部分内容阅读
目的:探讨分析头孢拉定静滴发生血尿的相关因素。方法:收集本院急诊科近1年来接诊的患者在应用头孢拉定静滴进行抗感染治疗中出现的18例血尿现象进行讨论分析。结果:(1)18例血尿患者以青壮年居多;(2)血尿多发生在输液完毕后1小时内;(3)血尿的发生可能与药物的剂量、配药浓度、个体过敏体质及药品的质量有关。结论:提请临床医师、药师在使用头孢拉定时,严格掌握其剂量、浓度及输注速度,以减少不良反应的发生。
Objective: To analyze and analyze the related factors of cefradine-induced hematuria. Methods: 18 patients with hematuria who were treated with cefradine infusion in anti-infective therapy were collected and analyzed in the emergency department of our hospital in the past year. Results: (1) 18 cases of hematuria were mostly young adults; (2) hematuria occurred more than 1 hour after the infusion was completed; (3) the occurrence of hematuria may be related to the dosage of drugs, drug concentration, related. Conclusions: Clinicians and pharmacists are urged to strictly control the dose, concentration and infusion rate of cefradine to reduce the incidence of adverse reactions.